Connected Health Devices - Global Market Trajectory & Analytics

Global Connected Health Devices Market to Reach $52.1 Billion by 2027

Amid the COVID-19 crisis, the global market for Connected Health Devices estimated at US$16.3 Billion in the year 2020, is projected to reach a revised size of US$52.1 Billion by 2027, growing at a CAGR of 18.1% over the period 2020-2027. Personal Medical Devices, one of the segments analyzed in the report, is projected to record 20.5% CAGR and reach US$33.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Wellness Devices segment is readjusted to a revised 14.6% CAGR for the next 7-year period.



The U.S. Market is Estimated at $4.9 Billion, While China is Forecast to Grow at 17.6% CAGR

The Connected Health Devices market in the U.S. is estimated at US$4.9 Billion in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$9.1 Billion by the year 2027 trailing a CAGR of 17.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 16.4% and 14.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 12.2% CAGR.

Select Competitors (Total 38 Featured):

• Abbott India Limited
• Agfa-Gevaert NV
• Alcatel-Lucent SA
• Allscripts Healthcare Solutions, Inc.
• Apple, Inc.
• Athenahealth, Inc.
• CardioNet
• Epic Systems Corporation
• Evolent Health
• F. Hoffmann-La Roche AG
• GE Healthcare
• Google, Inc.
• Hewlett-Packard Development Company LP
• Honeywell Life Care Solutions
• Johnson & Johnson
• Medtronic PLC
• Microsoft Corporation
• Misfit, Inc.
• Omron Healthcare, Inc.
• Philips Healthcare
• Proteus Digital Health, Inc.
• Skyscape Medpresso, Inc.
• STANLEY Healthcare
• Warby Parker
• WellDoc, Inc.
• Zebra Technologies Corporation